Hypera Pharma
@hyperapharma • Joined October 25, 2010
At a glance
Subscribers
Last 29 days71.3K
Views
Last 29 days190M
Videos
Last 29 days115
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
1.65M
Total views ÷ total videos
Views per subscriber
2,665×
Total views ÷ subscribers
Subs per video
620
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $133K – $380K
Daily avg.: $1 – $3
Weekly avg.: $6 – $18
Last 29 days: $26 – $74
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:Hypera Pharma
| Date | subscribers | views | videos |
|---|---|---|---|
Jun 1, 2026 Jun 1 Mon | 71.3K -- | 190M +9.63K | 115 -- |
May 25, 2026 May 25 Mon | 71.3K -- | 190M +8.24K | 115 -- |
May 18, 2026 May 18 Mon | 71.3K -- | 190M +9.31K | 115 -- |
May 11, 2026 May 11 Mon | 71.3K -- | 189M +8.56K | 115 -- |
May 9, 2026 May 9 Sat | 71.3K -- | 189M +22.6K | 115 -- |
Apr 21, 2026 Apr 21 Tue | 71.3K -- | 189M -- | 115 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
May 9, 2026 | 0 | -- |
May 11, 2026 | 0 | -- |
May 18, 2026 | 0 | -- |
May 25, 2026 | 0 | -- |
Jun 1, 2026 | 0 | -- |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
May 9, 2026 | 22.6K | +22.6K |
May 11, 2026 | 8.56K | -14.0K |
May 18, 2026 | 9.31K | +751 |
May 25, 2026 | 8.24K | -1.07K |
Jun 1, 2026 | 9.63K | +1.38K |
About
A Hypera tem o DNA de uma empresa líder no mercado farmacêutico brasileiro. Tem orgulho de ser 100% nacional, levando seus produtos para mais de 200 milhões de brasileiros e participando da vida das pessoas para que elas vivam mais e melhor. Nossa missão: dar acesso à saúde para a população brasileira, oferecendo prod…
- Handle
- @hyperapharma
- Joined
- October 25, 2010
More features coming
We're working on new analytics and tools. Stay tuned.
More features coming
We're working on new analytics and tools. Stay tuned.